Capillary gas chromatographic assay of residual methenamine hippurate in equipment cleaning validation swabs

Journal of Pharmaceutical and Biomedical Analysis

Volumn 16, Issue 6, 1998, Pages 939-950

  Mirza, Tahseen ^a   George, Ron C ^a   Bodenmiller, John R ^a   Belanich, Stephen A ^a  

^a Blg 32 2 ^*  (United States)

Author keywords

Cleaning validation; GC FID; Methenamine hippurate; Swab analysis

Indexed keywords

DRUG RESIDUE; METHENAMINE HIPPURATE;

ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CLEANING; DRUG ABSORPTION; DRUG DETERMINATION; DRUG MANUFACTURE; DRUG STABILITY; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS, URINARY; CALIBRATION; CHROMATOGRAPHY, GAS; DRUG COMPOUNDING; DRUG RESIDUES; DRUG STABILITY; HIPPURATES; METHENAMINE; NEOPRENE; POLYTETRAFLUOROETHYLENE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; STAINLESS STEEL;

EID: 0032006070     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(97)00059-9     Document Type: Article

References (17)

1. [1] Physicians' Desk Reference, 43rd Edition, Medical Economics Company Inc., Oradell, NJ, 1989, p. 1415.
2. [2] The Merck Index, 11th Edition, Merck and Company Inc., Rahaway, NJ, 1989, p. 5888.
3. [3] J.K. Lim, C.C. Chen, J. Pharm. Sci. 62 (9) (1973) 1503-1504.
4. [4] J.G. Strom Jr., H.W. Jun, J. Pharm. Sci. 4 (1986) 416-420.
5. [5] F.A.N. Onur, Int. J. Pharm. 78 (1992) 89-91.
6. [6] E. Klinge, P. Mannisto, R. Mantyla, J. Antimicrob. Chemother. 9 (3) (1982) 209-216.
7. [7] J.G. Strom Jr., H.W. Jun, J. Pharm. Sci. 66 (4) (1977) 89-90.
8. [8] J.O. Levin, I. Fangmark, Analyst 113 (3) (1988) 511-513.
9. [9] G.L. Madsen, D.S. Crumrine, B. Jaselskis, Analyst 121 (4) (1996) 567-570.
10. [10] U.S. Pharmacopeia 23 and National Formulatory 18, First Supplement, 23rd Revision, United States Pharmacopeial Convention Inc., Rockville, MD, pp. 2478-2479.
11. [11] Guide to Inspections of Validation of Cleaning Processes, Reference Material for FDA Investigators and Personnel, Food and Drug Administration, Washington, DC, July 1993, pp. 1-6.
12. [12] D.B. Barr, W.C. Crabbs, D. Cooper, Pharm. Technol. 9 (17) (1993) 54-70.
13. [13] D.W. Mendenhall, Drug Dev. Ind. Pharm. 15 (13) (1989) 2105-2114.
14. [14] J. Agalloco, J Parenteral Sci. Technol. 46 (5) (1992) 163-168.
15. [15] S.W. Harder, Pharm. Technol. 8 (5) (1984) 29-34.
16. [16] K.M. Jenkins, A.J. Vanderwielen, Pharm. Technol. 18 (4) (1994) 60-73.
17. [17] G.L. Fourman, M.V. Mullen, Pharm. Technol. 17 (4) (1993) 54-60.